About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Texas | 723 Studies

Clinical Trials Colorectal CancerTexas

Colorectal Cancer Clinical Trials in Texas

Find 723 clinical trials for colorectal cancer near Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 701-720 of 723 trials

CompletedFR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as FR901228, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00077337·Mobile, Alabama and 87 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesThe primary purpose of this study is to see if Sym024 is safe and tolerable as monotherapy and in combination with Sym021 in patients with solid tumor malignancies.NCT04672434·Grand Rapids, Michigan and 3 others

RecruitingA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)Researchers want to learn if sacituzumab tirumotecan (MK-2870) alone or with other treatments can treat certain gastrointestinal (GI) cancers.NCT06428409·Los Angeles, California and 54 others

RecruitingStudy of CP-383 in Patients With Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383.NCT07030257·Denver, Colorado and 12 others

RecruitingFOG-001 in Locally Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial…NCT05919264·Phoenix, Arizona and 32 others

UnknownDoctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By SurgeryThe goal of this study is to compare the effects of exercise with the effects of relaxation training on physical function (how well participants perform normal daily activities)…NCT00985400·Houston, Texas

RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationThe purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors.NCT05059444·Birmingham, Alabama and 56 others

CompletedA Study of ABT-165 in Subjects With Solid TumorsThis is a Phase 1/1b open-label study evaluating the safety, pharmacokinetics (PK), and preliminary efficacy of ABT-165 when administered as monotherapy and in combination with…NCT01946074·Scottsdale, Arizona and 9 others

CompletedStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyStudy of NGM120 in subjects with advanced solid tumors and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).NCT04068896·Tucson, Arizona and 19 others

CompletedA Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesThis is a Phase 1, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity of…NCT03629756·Scottsdale, Arizona and 14 others

RecruitingA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsThis is a study to evaluate the safety and potential anti-tumor activity of an investigational drug called ARV-6723, in participants with advanced solid tumors.NCT07749586·Huntersville, North Carolina and 2 others

RecruitingA Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsThe purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.NCT06835569·Orlando, Florida and 11 others

CompletedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03662204·Phoenix, Arizona and 118 others

RecruitingOpen-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsFirst in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with other anti-cancer agents in…NCT06625775·Duarte, California and 43 others

CompletedA First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid TumorsThis is a phase 1, multi-center, dose escalation, open-label study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of…NCT03518554·Denver, Colorado and 3 others

Active not recruitingFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentThis research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment.NCT03516942·Anchorage, Alaska and 715 others

CompletedStudy to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX AloneThis clinical trial will be performed in previously untreated patients with metastatic colorectal cancer.NCT00890305·Huntsville, Alabama and 30 others

RecruitingA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid TumorsThe purpose of this study is to investigate the study drug, OKN4395, administered alone and in combination with pembrolizumab.NCT06789172·Beverly Hills, California and 9 others

RecruitingA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesThis is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx)…NCT06395519·Phoenix, Arizona and 13 others

TerminatedPF-06671008 Dose Escalation Study in Advanced Solid TumorsThe study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of PF-06671008 in patients with advanced solid tumors with the potential to have…NCT02659631·Harrison, New York and 8 others

PreviousPage 36 of 37Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma